The Board has remanded the case due to insufficient etiology opinions regarding the Veteran's CAA with dementia, including AL amyloidosis. The VA needs to obtain an adequate opinion on whether it is at least as likely as not that the condition onset during service or is related to service exposure.
The deciding factor: The Board found insufficient evidence in the record addressing the etiology of the Veteran's diagnosed CAA with dementia, including AL amyloidosis.
- Claimed conditions
- CAA (Cerebral Amyloid Angiopathy) with dementia, including AL amyloidosis
- How they argued it
- Not specified
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- May 4, 2022
- Citation
- 22026426
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 22026426.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.